Decorporation of thorium-228 from the rat by 3,4,3-LIHOPO and DTPA after simulated wound contamination. 1995

G N Stradling, and S A Gray, and M J Pearce, and I Wilson, and J C Moody, and R Burgada, and P W Durbin, and K N Raymond
National Radiological Protection Board, Didcot, Oxon, UK.

1. With DTPA as a comparison, the siderophore analogue 3,4,3-LIHOPO has been examined for its ability to remove 228Th nitrate from the rat after subcutaneous (sc) and intramuscular (im) injection to simulate wound contamination. The commencement of treatment was delayed 30 min, 6 h or 1 d and the animals killed at 7 d. 2. In all cases 3,4,3-LIHOPO was appreciably more effective than DTPA although the efficacy of treatment and the relative effectiveness of the ligands decreased rapidly with their delay in administration. 3. Optimum removal with both ligands occurred when initial local administration at 30 min after exposure was followed by repeated intraperitoneal injection at 6 h, 1, 2 and 3 d. Under these conditions the body content of 228Th was reduced to 20% of controls after sc injection and 15% after im injection. The corresponding values using repeated DTPA administration were 80% and 54%. 4. It is concluded that 3,4,3-LIHOPO represents, potentially, a considerable advance on DTPA, the current agent of choice for the treatment of wounds contaminated by 228Th.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004369 Pentetic Acid An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium. DTPA,Diethylenetriamine Pentaacetic Acid,Pentetates,Penthanil,Ca-DTPA,CaDTPA,CaNa-DTPA,Calcium Trisodium Pentetate,DETAPAC,Indium-DTPA,Mn-Dtpa,Pentacin,Pentacine,Pentaind,Pentetate Calcium Trisodium,Pentetate Zinc Trisodium,Sn-DTPA,Zinc-DTPA,Indium DTPA,Pentaacetic Acid, Diethylenetriamine,Pentetate, Calcium Trisodium,Zinc DTPA
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

G N Stradling, and S A Gray, and M J Pearce, and I Wilson, and J C Moody, and R Burgada, and P W Durbin, and K N Raymond
January 2003, Radiation protection dosimetry,
G N Stradling, and S A Gray, and M J Pearce, and I Wilson, and J C Moody, and R Burgada, and P W Durbin, and K N Raymond
January 2000, International journal of radiation biology,
G N Stradling, and S A Gray, and M J Pearce, and I Wilson, and J C Moody, and R Burgada, and P W Durbin, and K N Raymond
December 1995, International journal of radiation biology,
G N Stradling, and S A Gray, and M J Pearce, and I Wilson, and J C Moody, and R Burgada, and P W Durbin, and K N Raymond
July 1996, International journal of radiation biology,
G N Stradling, and S A Gray, and M J Pearce, and I Wilson, and J C Moody, and R Burgada, and P W Durbin, and K N Raymond
June 1993, International journal of radiation biology,
G N Stradling, and S A Gray, and M J Pearce, and I Wilson, and J C Moody, and R Burgada, and P W Durbin, and K N Raymond
March 2012, International journal of radiation biology,
G N Stradling, and S A Gray, and M J Pearce, and I Wilson, and J C Moody, and R Burgada, and P W Durbin, and K N Raymond
June 1977, Health physics,
G N Stradling, and S A Gray, and M J Pearce, and I Wilson, and J C Moody, and R Burgada, and P W Durbin, and K N Raymond
October 1995, International journal of radiation biology,
G N Stradling, and S A Gray, and M J Pearce, and I Wilson, and J C Moody, and R Burgada, and P W Durbin, and K N Raymond
April 1986, Health physics,
G N Stradling, and S A Gray, and M J Pearce, and I Wilson, and J C Moody, and R Burgada, and P W Durbin, and K N Raymond
October 1993, International journal of radiation biology,
Copied contents to your clipboard!